News

­
28 06, 2016

Transferra Nanosciences Inc. Enters into a Sale Agreement with Evonik Industries

An agreement concerning the acquisition of the business and assets of Transferra Nanosciences Inc. (formerly Northern Lipids Inc.) by Evonik Industries was signed June 21, 2016.

Mr. Don Enns , President and CEO Transferra Nanosciences Inc. and Dr. Jean-Luc Herbeaux, Senior VP and Head of the Health Care Business Line at Evonik [...]</p data-lazy-srcset=

24 05, 2016

Nanomedicines Symposium, Seattle, Washington (July 16)

TRANSFERRA will be presenting at the Nanomedicines: Materials, Manufacturing and Therapeutic Applications Symposium in Seattle, Washington on July 16. We will be giving a talk titled ‘Liposomes from Prototype to Manufacturing for the Clinic.’ Register for the live event or join us via webcast.

10 05, 2016

CRS Annual Meeting and Exposition, Seattle, Washington (July 17-20)

TRANSFERRA is a proud sponsor of the Controlled Release Society Annual Meeting & Exposition in Seattle, Washington. Look for us at Booth 604 in the Exposition Hall from July 17-20.